Featuring contributions from leading Japanese clinical neurologists, this new publication focuses on the basic and clinical neuroprotective therapeutic approaches to Parkinson's disease. These treatment strategies are thoroughly discussed throughout the volume and include articles on some of the fundamental aspects of neuroprotection such as molecular biology of glutamic acid receptor channels, neuroprotection by glutamate receptor antagonists and the influence of nutritional factors on neuronal cells. Special attention is also placed on the current therapeutic approaches to Parkinson's disease-L-dopa therapy, therapy with L-dopa and its agonists, dopamine agonist therapy and monoamine oxidase inhibitor therapy. This comprehensive publication will be of direct benefit to neurologists involved in the treatment of Parkinson's disease.
